Note: Ingredients listed on restricted chemical lists
EC/CAS
69-65-8
Name of the chemical
D-mannitol C6H14O6
Concentration
81.1%
General Information
Revision date
2014-07-02
Product name
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection
Emergency telephone
1-800-221-7554
Icons in SDS
Company Information
company name
Pharmalucence, Inc
Section 2
Potential health effects
Eye Contact: May cause irritation. Skin Contact: Exposure may occur via skin contact if gloves and protective clothing are not worn. The extent of systemic absorption of the material after skin contact is not known. Toxic: Contact with small quantities of material for short periods is not expected to result in pharmacologic or toxic effects. Irritation: Material contains components that are irritants. It may have potential to cause mild irritation; however, moderate or severe irritation is not expected. Inhalation: Under normal conditions, this material is handled in closed vials and exposure by inhalation is not expected to occur. Acute: Formulation contains some materials that are irritants. Inhaling small amounts of dust may result in irritation. Ingestion: Ingestion of large quantities of this material in an occupational setting would not be expected to occur. Ingestion of trace amounts of the material might occur if the material contacts hands and hands are not washed prior to eating, drinking or smoking. The extent of systemic absorption after ingestion is not known. Acute: Inadvertent ingestion of trace amounts of this material would not be expected to result in symptoms.
Potential chronic health
Repeated and prolonged exposure to skin may cause skin irritation. 2 Carcinogenicity Information None of the components present in this material at concentrations equal to or greater than 0.1% are listed by IARC NTP